Side effects include:
Patients with psoriasis: Nasopharyngitis,  upper respiratory tract infection,  headache,  fatigue,  diarrhea,  back pain,  dizziness,  pharyngolaryngeal pain,  pruritus,  injection site erythema,  myalgia,  depression.

Patients with psoriatic arthritis: Arthralgia,  nausea,  dental infections.

Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, oropharyngeal painUncommon (0.
1% to 1%): Nasal congestion
Common (1% to 10%): Headache, dizzinessUncommon (0.
1% to 1%): Facial palsy
Common (1% to 10%): Fatigue
Common (1% to 10%): Diarrhea, nausea
Common (1% to 10%): Back pain, myalgia, arthralgia
Common (1% to 10%): Injection site erythema, pain, bruising, irritationUncommon (0.
1% to 1%): Injection site reactions (including hemorrhage, hematoma, induration, swelling, and pruritus)
Common (1% to 10%): PruritusUncommon (0.
1% to 1%): Pustular psoriasis, skin exfoliationRare (less than 0.
1%): Exfoliative dermatitisPostmarketing reports: Erythrodermic psoriasis
Common (1% to 10%): Depression
Common (1% to 10%): Malignancies (1.
7%)Postmarketing reports: Rapidly appearing, multiple cutaneous squamous cell carcinomas
Uncommon (0.
1% to 1%): Hypersensitivity reactions (including rash, urticaria)Rare (less than 0.
1%): Serious hypersensitivity reactions (including anaphylaxis and angioedema)
Very common (10% or more): Infections (up to 27%)Common (1% to 10%): About 6% of patients developed antibodies to this drug, dental infectionsUncommon (0.
1% to 1%): Cellulitis, herpes zoster, viral upper respiratory tract infection
It is possible that some side effects of Stelara may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.